Institutional investors bought shares in Northrop Grumman Corporation, and Morgan Stanley provided a price objective on the stock.
1 report, 1 independent
Updated Aug 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Institutional investors bought shares in Northrop Grumman Corporation, and Morgan Stanley provided a price objective on the stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Northrop Grumman Corporation
American aerospace and defense technology corporation
-
Morgan Stanley
U.S. investment bank
Related events
- Morgan Stanley issued a rating and price target for Trevi Therapeutics, Inc. on August 28, 2026.
- SEC filing tracks institutional investment activity involving Morgan Stanley and Buy.
- Northrop Grumman Corporation (NOC) stock lagged behind the broader market performance on August 18, 2026.
- Morgan Stanley issued research reports and price targets, while institutional investment disclosures were filed with the SEC regarding a new stake purchase in Stanley Black & Decker.
- AutoZone's board authorized a stock buyback program amid increased stakes by Norges Bank and Morgan Stanley, requiring SEC filings.